# DARIFENACIN HYDROBROMIDE
> **ANDA209571** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2019-10-22
## Drug
- **FDA Application Number:** ANDA209571
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DARIFENACIN HYDROBROMIDE
- **Generic name:** Darifenacin Hydrobromide
- **Active ingredients:** DARIFENACIN HYDROBROMIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** XIROMED
- **First approval:** 2019-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209571)
---
*MORVS · CC0 1.0*